News Summary: Targeted cancer drug approved

Print
Email
|

Associated Press

Posted on February 22, 2013 at 5:01 PM

Updated Friday, Feb 22 at 5:02 PM

WASHINGTON (AP) — SMART BOMB DRUG: Federal health regulators approved an innovative breast cancer drug on Friday that targets tumor cells while sparing healthy ones.

PHARMA COCKTAIL: The drug Kadcyla from Roche combines the older drug Herceptin with a powerful chemotherapy drug and a third chemical linking the medicines together.

TUMOR TARGETING: The binding chemical keeps the cocktail intact until it hits a cancer cell, delivering a potent dose of anti-tumor poison.

Print
Email
|